"The $1 Trillion Question: Why America’s Branded Drug Market is a Recipe for Disaster
As the US grapples with the rising costs of healthcare, a staggering truth emerges: the country’s reliance on branded medications is driving a multibillion-dolla…
The Billionaire’s Crusade Against Big Pharma: Mark Cuban’s Unlikely War on Drug Prices
In a surprise move, billionaire entrepreneur Mark Cuban has taken aim at the pharmaceutical industry, launching a scathing critique of the high prices of prescriptio…
Dunking on the Pharma Industry: An In-Depth Analysis of Mark Cuban’s War on Drug Prices Read Post »
The Patent Defense Paradox: Why Pharma Companies Need to Shift Their Strategy
As the pharmaceutical industry continues to grapple with the complexities of patent defense, a growing number of companies are realizing that the traditional approach to prot…
The Unseen Threat to Big Pharma’s Dominance: How Smarter API Manufacturing is Redefining the Industry
As the pharmaceutical landscape continues to evolve, a seismic shift is taking place that threatens to upend the traditional power dynamics between Bi…
How Smarter API Manufacturing Is Eating Big Pharma’s Lunch Read Post »
The Unspoken Truth About Winning Drug Patent Challenges: It’s Not About the Patent, It’s About the Market
As the pharmaceutical industry grapples with the complexities of patent law, a crucial aspect of the game often goes unspoken: winning the market,…
The Hidden Threat to Biomedical Research: Why Business Continuity Planning Must Become a Priority
As the world grapples with the COVID-19 pandemic, the importance of business continuity planning (BCP) has never been more apparent. For biomedical and re…
The Secret to Dominating a Market You Don’t Own: How to Win in the Post-Patent Era
As the pharmaceutical industry continues to evolve, one thing is clear: the days of patent-protected monopolies are numbered. With patent expirations on the rise, generi…
How to own a Market you Don’t Own: Market Access Strategies Post-Patent Expiration Read Post »
"Uncovering the Secret Formulas: How Pharmaceutical Companies Use Patents to Outmaneuver Competitors
As the pharmaceutical industry continues to evolve, companies are turning to innovative strategies to stay ahead of the curve. But what if we told…
Cracking the Code: Using Drug Patents to Reveal Competitor Formulation Strategies Read Post »
The Uncharted Territory of Biosimilars: How Pharmaceutical Companies Are Rethinking Patent Strategies to Stay Ahead in a Rapidly Evolving Market
As the pharmaceutical industry grapples with the complexities of biologic innovation and market access, a n…
"The Secret Sauce Behind Breakthroughs: How Researchers and Policymakers Are Cracking the Code on Expired Patents
As the pharmaceutical industry grapples with rising R&D costs and stagnant innovation, a quiet revolution is underway. Behind the…
How Academic Researchers and Policy Experts Use DrugPatentWatch Read Post »
Get new actionable insights and updates from BiotechBlog
